IP Library Granted Patent US 9,045,520
Granted Patent B2
US 9,045,520 · App. 13/491,437 · Granted Jun 2, 2015

Synthesis of purine nucleosides

Inventors: Byoung-Kwon Chun (Robbinsville, NJ); Jinfa Du (New Hope, PA); Suguna Rachakonda (Twinsburg, OH); Bruce Ross (Plainsboro, NJ); Michael Joseph Sofia (Doylestown, PA); Ganapati Reddy Pamulapati (Plainsboro, NJ); Wonsuk Chang (Princeton, NJ); Hai-Ren Zhang (Ellicott City, MD); Dhanpalan Nagarathnam (Bethany, CT)
Assignee: GILEAD PHARMASSET LLC
C07H19/20C07H1/00C07H15/04C07H5/02C07H19/167C07H19/213
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,045,520
App. No.
13/491,437
Granted
Jun 2, 2015
Kind
B2
Abstract

A process for preparing phosphoramidate prodrugs or cyclic phosphate prodrugs of nucleoside derivatives, which is a compound, its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof.

Claims (19)

1. A compound of formula IV:

or a salt thereof, wherein:

R 5 is H or N 3 ;

R 6 is CH 3 ;

R 11 is a protecting group; and

X is F.

2. A compound of formula V:

or a salt thereof, wherein:

R 5 is N 3 ;

R 6 is CH 3 ;

R 11 is a protecting group;

X is F; and

X′ is Cl, Br, or I.

3. The compound of claim 1 , wherein R 5 is H.

4. A process for preparing a compound of formula IV, wherein said process comprises:

(a) stereoselective reduction of a compound of formula III using a hydride reducing agent to provide a mixture comprising a compound of formula IV and a compound of formula IV-α:

and

(b) crystallizing the compound of formula IV from the mixture comprising the compounds of formula IV and formula IV-α:

wherein R 11 is a protecting group.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2022
From: GILEAD PHARMASSET LLC
To: GILEAD SCIENCES, INC.
Reel/Frame 060217/0818 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 032588 FRAME 0907. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE NAME AS GILEAD PHARMASSET LLC. Recorded Apr 4, 2014
From: PHARMASSET, INC.
To: GILEAD PHARMASSET LLC
Reel/Frame 032607/0189 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME AND ASSIGNEE CITY ADDRESS PREVIOUSLY RECORDED ON REEL 031580 FRAME 0282. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE NAME AS GILEAD PHARMASSET LLC AND THE ASSIGNEE CITY ADDRESS AS FOSTER CITY. Recorded Apr 1, 2014
From: PHARMASSET, INC.
To: GILEAD PHARMASSETT LLC
Reel/Frame 032588/0907 →
CHANGE OF NAME Recorded Nov 5, 2013
From: PHARMASSET, INC.
To: GILEAD PHARMASSET, INC.
Reel/Frame 031580/0282 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2013
From: CHUN, BYOUNG-KWON; DU, JINFA; ROSS, BRUCE; SOFIA, MICHAEL JOSEPH; PAMULAPATI, GANAPATI REDDY; CHANG, WONSUK; ZHANG, HAI-REN; RACHAKONDA, SUGUNA; NAGARATHNAM, DHANAPALAN
To: PHARMASSET, INC.
Reel/Frame 031533/0340 →
Continuity (3)
Division 12645821 · Dec 23, 2009
Provisional Application 61140317 · Dec 23, 2008
Related Publication 20120316327A1 · Dec 13, 2012